Background Despite omega-3 polyunsaturated fatty acids (PUFA) supplementation in
depressed patients have been suggested to improve depressive symptomatology, previous …

We conducted this meta-analysis of double-blind randomized placebo-controlled trials to
estimate the efficacy of omega-3 polyunsaturated fatty acids (PUFAs), especially …

Omega-3 polyunsaturated fatty acid (PUFA) supplementation has been proposed as
(adjuvant) treatment for major depressive disorder (MDD). In the present meta-analysis, we …

We conducted a meta-analysis of randomized, placebo-controlled trials of omega-3 fatty
acid (FA) treatment of major depressive disorder (MDD) in order to determine efficacy and to …

BackgroundTrials evaluating efficacy of omega-3 highly unsaturated fatty acids (HUFAs) in
major depressive disorder report discrepant findings. AimsTo establish the reasons …

Objective: Evidence has indicated an association between depression and low dietary
intake of omega-3 polyunsaturated fatty acids (PUFAs). However, clinical trials examining …

Background Major depressive disorder (MDD) is highly debilitating, difficult to treat, has a
high rate of recurrence, and negatively impacts the individual and society as a whole. One …

Objective: Randomized trials of omega-3 polyunsaturated fatty acid (PUFA) treatment for
depression have differed in outcome. Recent meta-analyses ascribe discrepancies to …

Background: Epidemiologic and case-control data suggest that increased dietary intake of
omega-3 long-chain polyunsaturated fatty acids (ω3 LC-PUFAs) may be of benefit in …

One of the typical symptoms of a psychological crisis is depression, an increasing concern in
the elderly population. Although omega-3-polyunsaturated fatty acids (PUFAs) are reported …